Yohimbine HCL
Also known as: Yohimbine HCl, Yohimbine, Yohimbe (bark), Aphrodine, Corynine, Quebrachine, Yohimbine hydrochloride
Overview
Yohimbine HCl is a purified chemical form of yohimbine, an indole alkaloid extracted from the bark of the African Pausinystalia yohimbe tree. It is primarily utilized as a pharmacological agent for the treatment of erectile dysfunction (ED) and is also marketed for weight loss and athletic performance enhancement. Its mechanism of action involves acting as an alpha-2 adrenergic receptor antagonist, which leads to an increase in sympathetic nervous system activity and improved peripheral blood flow. Research on yohimbine's efficacy for ED is moderately robust, supported by several randomized controlled trials and meta-analyses. However, evidence for its use in weight loss and other applications is less conclusive, often relying on preclinical or observational data. The quality of evidence for ED treatment is considered moderate, showing statistically significant benefits, though some study heterogeneity exists.
Benefits
The primary evidence-based benefit of Yohimbine HCl is the treatment of erectile dysfunction (ED). A 2021 systematic review and meta-analysis of 8 RCTs demonstrated that yohimbine alone significantly improved erectile function compared to placebo (Odds Ratio [OR] = 2.08, 95% Confidence Interval [CI] 1.30-3.32, p=0.002). When combined with other treatments, the effect size was even greater (OR = 6.35, 95% CI 3.01-13.41, p<0.001). While yohimbine monotherapy did not significantly improve overall sexual function (p=0.07), a pooled analysis indicated a higher rate of improved sexual function across all subgroups (OR = 2.65, 95% CI 1.43-4.92, p=0.002). These benefits are primarily observed in men with organic ED. Potential modest weight loss effects have been noted in animal studies, but human data are insufficient and inconclusive, making it not a recommended primary use.
How it works
Yohimbine functions as a selective alpha-2 adrenergic receptor antagonist. By blocking these inhibitory presynaptic receptors, it leads to an increased release of norepinephrine, a neurotransmitter. This action enhances sympathetic nervous system activity, resulting in increased peripheral vasodilation and improved blood flow, particularly to erectile tissue. Yohimbine may also exert influence on central nervous system pathways that are involved in sexual arousal. Yohimbine HCl is the standardized form used to ensure consistent absorption and dosing, as the oral bioavailability of yohimbine can otherwise be variable.
Side effects
Yohimbine is generally safe at therapeutic doses but possesses a narrow therapeutic window, meaning the difference between an effective dose and a toxic dose is small. Common side effects, affecting more than 5% of users, include anxiety, nervousness, increased heart rate (tachycardia), elevated blood pressure (hypertension), nausea, dizziness, and insomnia. Less common side effects (1-5%) may include palpitations, urinary frequency, and diarrhea. Rare but severe adverse events, reported in less than 1% of cases, include neurotoxicity leading to seizures, hypertensive crisis, renal failure, and lupus-like syndrome, often associated with overdose or product contamination. Yohimbine should be used with caution alongside antihypertensives, psychiatric medications, and stimulants due to potential additive cardiovascular and central nervous system effects. It is contraindicated in individuals with cardiovascular disease, hypertension, psychiatric disorders (e.g., mania, schizophrenia), pregnancy, and renal or liver disease. Use is not recommended for pregnant or breastfeeding women, or those with pre-existing cardiovascular or psychiatric conditions.
Dosage
For erectile dysfunction, clinical trials typically recommend an oral dosage of 5.4 to 6 mg, taken 2-3 times daily. The optimal daily dosage generally ranges from 15-20 mg, divided into multiple doses, though individual tolerance and study protocols vary. It is crucial not to exceed a maximum safe dose of 30 mg per day due due to the increased risk of adverse effects. For acute effects related to sexual activity, yohimbine is often taken 30-60 minutes beforehand. Yohimbine HCl is the preferred form for consistent dosing compared to raw yohimbe bark extracts. Food may delay absorption, so taking it in a fasted state might improve bioavailability. No specific cofactors are required, but monitoring cardiovascular status is advisable during use.
FAQs
Is yohimbine safe for long-term use?
Long-term safety data for yohimbine are limited. Short-term use under medical supervision is generally preferred to mitigate potential risks and monitor for adverse effects.
Can yohimbine cause high blood pressure?
Yes, yohimbine can increase both blood pressure and heart rate. This risk is particularly elevated at higher doses or in individuals who are sensitive to its effects.
Does yohimbine work alone or only combined?
Yohimbine alone has been shown to improve erectile function. However, its efficacy may be enhanced when used in combination with other agents, as suggested by research.
How quickly does it work?
Effects on erectile function can be observed within days to weeks of consistent use. For acute effects, it is often taken 30-60 minutes before sexual activity.
Is it effective for weight loss?
Evidence for yohimbine's effectiveness in weight loss is insufficient and primarily derived from animal studies. It is not recommended as a primary supplement for weight loss.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9612744/ – This systematic review and meta-analysis from Turk J Urol (2021) included 8 RCTs and found that yohimbine significantly improved erectile function compared to placebo (OR=2.08). The effect was even greater when combined with other treatments (OR=6.35). The study noted some heterogeneity but provided moderate-quality evidence for yohimbine's efficacy in ED.
- https://pubmed.ncbi.nlm.nih.gov/9649257/ – An older meta-analysis published in J Urol (1998) provided foundational evidence, showing yohimbine to be superior to placebo for ED treatment (OR 3.85). While based on older studies with smaller sample sizes, it contributed to the understanding of yohimbine's efficacy, offering moderate-quality evidence.
- https://www.mskcc.org/cancer-care/integrative-medicine/herbs/yohimbe – This resource from Memorial Sloan Kettering Cancer Center compiles case reports and safety reviews, documenting severe adverse events such as hypertensive crises, seizures, and fatalities linked to yohimbine overdose or contamination. It underscores the critical need for cautious dosing, proper product quality, and medical supervision due to significant safety concerns.
Supplements Containing Yohimbine HCL

Fireball TNT
Precision Engineered

Redline
Redline

Atro-phex
BSN

Lipo 6 Black
Nutrex Research

Lipo 6 Black Hers
Nutrex Research

Lipo 6 Black
Nutrex Research

Methylburn Extreme
MuscleMeds

Lipo 6 Unlimited
Nutrex
